Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by Finallytherockon Dec 22, 2020 7:59pm
182 Views
Post# 32166529

RE:RE:RE:RE:RE:Should a comparison be made between Bioasis and Denali?

RE:RE:RE:RE:RE:Should a comparison be made between Bioasis and Denali?i think it makes some sense to compare us to dnli given we are in a similar space and it appears, at least right now, our platform is better. we can look at their market cap and dream that if our platform is truly better, where can this stock price go? i know there are some here who are frustrated. i get it. i owned this one years ago and sold because progress was so slow but i jumped in once we signed the chiasi deal because then i knew our platform finally had some validity and we had a big pharma steering the ship a bit. if this platform was as great as we believe, chiasi, at least, would bring it to fruition, i hold over 700K shares.  i am heavily invested here as i believe in the platform. dr rathjen recently stated on her podcast we will see data which will help promote partnerships in the first quarter. at this point, the best thing is just to wait and see. we are not that far off from seeing the data and since she was so emphatic about the data coming out first quarter, i can't imagine there will be more delays
<< Previous
Bullboard Posts
Next >>